The global market for diagnosing autoimmune diseases had a value of USD 8.0 billion in 2022 and is projected to reach USD 15.99 billion by 2032, with a compound annual growth rate (CAGR) of 8% during the forecast period. Several factors contribute to this market growth, including the increasing incidence of autoimmune diseases, advancements in […]
